je.st
news
23andMe will test DNA of 10,000 bowel disease patients in partnership with Pfizer
2014-08-12 19:33:44| Biotech - Topix.net
Pfizer Inc. is teaming up with DNA testing company 23andMe to study the possible genetic underpinnings of inflammatory bowel disease, a hard-to-treat ailment that affects an estimated 1.4 million Americans.
Tags: with
test
partnership
disease
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|